Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
FQuintero (talk | contribs)
editor
355 edits
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(142 intermediate revisions by 6 users not shown)
Line 1: Line 1:


{| class="wikitable"
{| class="wikitable"
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
|'''Disease'''||'''Page Type'''||'''Author'''||'''Associate Editor'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!Author Content (Pending or Complete)
!'''Date Assigned to Author'''
!Editor Reviewed (Date)
!'''Target Completion Date'''
!Notes
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|
|
|
|
|
|-
|-
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans+Jack Reid+Fabiola Quintero-Rivera
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
| ||FQR
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|
|complete
|
|FQR
|
|
|
|
Line 28: Line 42:
|    Polycythaemia Vera  (PV)||Disease
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|Gokce A. Toruner
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 35: Line 52:
|    Primary Myelofibrosis  (PMF)||Disease
|    Primary Myelofibrosis  (PMF)||Disease
|T. Niroshi  Senaratne
|T. Niroshi  Senaratne
|FQR
|
|
|
|
|complete
|
|FQR
|8/4/2020 before submission
|
|
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
| ||FQR
|(trainee), Daynna J.Wolff
|
|
|
|
|pending faculty review
|
|
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Mark Evans+ Fabiola Quintero-Rivera
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|FQR
|
|
|-
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|
|complete
| ||FQR
|
|
|
|
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 74: Line 110:
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|Shashi Shetty
|
|
|complete
|
|FQR
|FQR
|
|
|
|
|
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|FQR
|
|
|
|
|complete
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|FQR
|PENDING
|
|
|
|
|-
|Complete
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|FQR
|PENDING
|
|
|
|
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|FQR
|Complete
|Complete
|
|
|
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|FQR
|
|PENDING
|
|
|Complete
|
|
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu+Fabiola Quintero-Rivera
|    Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|FQR
|PENDING
|
|
|
|
|-
|Complete
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
|
|
|FQR
|
|
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|
|
|Complete
|
|FQR
|
|
|NON-WHO ENTITY
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|FQR
|Disease
|PENDING
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|
|Complete
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|NON-WHO ENTITY
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|PENDING
|
|
|Complete
|
|
|-
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du+Teresa Smolarek
|    Chronic Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|FQR
|
|PENDING
|
|
|Complete
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu+Teresa Smolarek
|    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Refractory Cytopenia of Childhood||Disease||Xiaoli Du+Teresa Smolarek
|    Juvenile Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|9/1/20
|PENDING
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
| || || ||
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|
|
|complete
|
|
|-
|FQR
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident
|Jennelle Hodge (JH)
|Complete
|
|
|
|
|-
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|Complete
|
|
|
|complete
|
|
|-
|FQR
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH
|PENDING
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang||JH
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|PENDING
|
|
|9/1/20
|pending
|
|
|-
|FQR
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH
|PENDING
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang||JH
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|9/1/20
|PENDING
|PENDING
|
|FQR
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Complete
|
|
|
|
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH
|Complete
|Complete
|
|FQR
|
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+Path Resident
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|JH
|
|
|Complete
|Complete
|
|FQR
|
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH
|    Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|Complete
|
|
|9/1/20
|PENDING
|
|
|-
|FQR
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH
|Complete
|
|
|
|
|-
|-
|    Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty||JH
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|Complete
|
|
|9/1/20
|PENDING
|
|
|-
|FQR
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH
|Complete
|Complete
|
|
|Need permission for figure?  Update WHO?
|FQR
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng  Choy via Greg Conboy (Monash Health)||JH
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Complete
|
|
|
|
|-
|complete
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH
|Complete
|
|
|Add WHO reference
|FQR
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Path Resident  (Iris Martin)||JH
|    Refractory Cytopenia of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|Complete
|
|
|9/1/20
|PENDING
|
|
|-
|FQR
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH
|Complete
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH
| || ||
|PENDING
|
|
|
|
|
|-
| ||
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar  Iqbal||JH
|Complete
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|Complete
|
|
|
|
|-
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH
|Complete
|Complete
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge||JH
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|Complete
|
|
|
|
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH
|Complete
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|Complete
|
|
|
|
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS
|
|
|-
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|Complete
|
|
|
|
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and  Jialing Huang||JH
|Complete
|Complete
|02/03/2021||JH / MS
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|Complete
|
|
|
|
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH
|Complete
|Complete
| ||JH / MS
|03/02/2021-MS
|
|
|Need permission for figure?
|-
|-
|    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley||JH
|    Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou
|
|
|Complete
|Complete
| ||JH / MS
|03/02/2021-MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|
|
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH
|Complete
|Complete
|
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|Complete
|
|
|
|
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH
|Complete
|Complete
|
|
|JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH
|    Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|PENDING
|
|
|
|Complete
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|-
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH
|    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|Complete
|
|
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH
|    Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease||Shashi Shetty
|PENDING
|
|
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH
|??
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH
|    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|??
|
|
|
|
|-
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng  Choy via Greg Conboy (Monash Health)
|JH
|Complete
|Complete
| ||JH / MS
|02/24/2021-MS (re-review)
|
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|Disease
|Daynna Wolff+Path Resident
|JH
|PENDING
|
|
|NON-WHO ENTITY
|
|Complete
| ||JH / MS
|
|Need permission for figure?  Update WHO?
|-
|-
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|Disease
|Daynna Wolff+Path Resident
|JH
|PENDING
|
|
|NON-WHO ENTITY
|-
| || || ||
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''|| ||YA
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
|Complete
| ||JH / MS
|
|
|Add WHO reference
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|YA
|
|PENDING
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
 
|
Lisa Smith + Yassmine Akkari
|
|YA
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|YA
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|Disease
|Helene Bruyere
|YA
|PENDING
|
|
|NON-WHO ENTITY
|-
| || || ||
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|SP
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|SP
|
|
|
|
|Complete
| ||JH / MS
|
|
|Need permission for figure?
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|SP
|
|
|
|
|Complete
| ||JH / MS
|
|
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|SP
|
|
|
|Jennelle Hodge to review
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|SP
|
|
|
|
|Jennelle Hodge to review
|Complete
|-
| ||JH / MS
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|SP
|
|
|
|
|Jennelle Hodge to review
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|SP
|
|
|
|
|Jennelle Hodge to review
|Complete
|-
| ||JH / MS
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|SP
|
|
|
|
|Jennelle Hodge to review
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|SP
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|   Waldenstrom Macroglobulinemia||Disease||Honey Reddi
|    Acute Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|SP
|
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Mu Heavy Chain Disease||Disease|| ||SP
|    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|   Gamma Heavy Chain Disease||Disease|| ||SP
|    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Alpha Heavy Chain Disease||Disease|| ||SP
|    Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|SP
|
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|Acute Myeloid Leukemia (AML) with Mutated FLT3
|SP
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|Complete
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|SP
|Disease
|
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|
|
|-
|PENDING
|    Plasma Cell Myeloma  Variants||Disease||Zhenya Tang
|SP
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|SP
|
|
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
| || ||
|
|
|
|
|
|
|-
| ||
|           Primary  Amyloidosis||Disease|| ||SP
|
|
|
|
|
|-
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease|| ||SP
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
|
|
| ||Yassmine Akkari (YA)
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease|| ||SP
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||YA
|         TEMPI Syndrome||Disease|| ||SP
|
|
|
|
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|SP
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|
|
|PENDING
|
|
|-
|YA
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|Follicular Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Testicular Follicular Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    In Situ Follicular Neoplasia||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra +
 
Lisa Smith + Yassmine Akkari
|
|
|Complete
|
|
|YA
|
|
|
|
|-
|-
|    Duodenal-Type Follicular Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|
|
|Complete
|
|
|-
|YA
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|SP
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease||Holli Drendel
|SP
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|PENDING
| ||YA
|
|
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|SP
|SP
|
|
|
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||
| || || ||
|
|
|
|
|SP
|
|
|-
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|SP
|
|
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|-
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|SP
|
|
|-
|   Waldenstrom  Macroglobulinemia||Disease||
|
|
|
|
|SP
|
|
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|    Mu Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|
|
|Complete
|5/26/2021||SP
|
|
|-
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|PENDING
|
|SP
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|           Primary  Amyloidosis||Disease||
|
|
|
| ||SP
|
|
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|         POEMS Syndrome||Disease||
|
|
|
| ||SP
|
|
|-
|         TEMPI Syndrome||Disease||
|
|
|
| ||SP
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|SP
|
|
|-
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|Complete
|5/28/2021||SP
|
|
|-
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|11/11/2020
|SP
|
|
|-
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|8/16/2020
|SP
|
|
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|PENDING
| ||SP
|
|
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|8/15/20
|PENDING
|
|SP
|
|
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|
|
|
|
|SP
|
|
|-
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|SP
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|PENDING
|
|Greg Corboy (GC)
|
|
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
| ||GC
|
|
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|-
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
| ||GC
|
|
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
| ||GC
|
|
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
| ||GC
|
|
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Complete
| ||GC
|
|
|-
|Primary Effusion Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Multicentric Castleman  Disease||Disease||
|
|
|
| ||GC
|
|
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|PENDING
| ||GC
|
|
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
| ||GC
|
|
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
| ||GC
|
|
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|-
|Aggressive NK-cell Leukemia||Disease||
|
|
|
| ||SP
|
|
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
| ||SP
|
|
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|-
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
| ||SP
|
|
|-
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|Complete
|1/21/2021
|SP
|
|
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|Complete
|1/21/2021
|SP
|
|
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|PENDING
| ||SP
|
|
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|    Lymphomatoid  Papulosis||Disease||
|
|
|
| ||SP
|
|
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|PENDING
| ||SP
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
| ||Greg Corboy (GC)
|
|
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|PENDING
|
|GC
|
|
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|-
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|-
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|-
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|-
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|-
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|-
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|-
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|-
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
|PTEN
|Beth Pitel
|
|
|
|
|Pending
|
|
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
|MLTT3
|
|
|
|
|
|
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
|
|
|
|
|
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
|
|
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
|MECOM
|Brian Davis
|
|
|
|
|Pending
|
|
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
|
|
|
|
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
|FGFR1(FLT2)
|Brian Davis
|
|
|
|
|Pending
|
|
|-
|Lymphomatoid Granulomatosis||Disease|| ||GC
|
|
|
|
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
|KMT2A
|
|
|
|
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|
|-
|-
|Plasmablastic Lymphoma||Disease|| ||GC
|DEK
|Wahab A. Khan
|
|
|
|
|Pending
|
|
|-
|Primary Effusion Lymphoma||Disease|| ||GC
|
|
|
|
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
|NUP214
|Wahab A. Khan
|
|
|
|
|Pending
|
|
|-
|   Multicentric Castleman  Disease||Disease|| ||GC
|
|
|
|
|
|
|-
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|RBM15
|
|
|
|
|
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
|
|
|
|
|
|
|-
|Burkitt Lymphoma||Disease|| ||GC
|
|
|
|
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
|MKL1
|
|
|
|
|
|
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
|
|
|
|
|
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
|
|
|
|
|
|
|-
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|DDX41
|Ying Zou
|8/7/20
|
|
|Pending
|
|
|
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
|
|
|
|
|
|
|-
|-
| || || ||
|ANKRD26
|
|
|
|
|
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|
|
|
|
|
|
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP
|
|
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP
|CUX1
|
|
|
|
|
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP
|
|
|
|
|
|
|-
|Aggressive NK-cell Leukemia||Disease|| ||SP
|
|
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''|| ||SP
|TET2
|
|
|
|
|
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease|| ||SP
|
|
|
|
|
|
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||SP
|
|
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||SP
|EZH2
|
|
|
|
|
|
|-
|    Severe Mosquito Bite  Allergy||Disease|| ||SP
|
|
|
|
|
|-
|Adult T-cell Leukemia/Lymphoma||Disease|| ||SP
|
|
|
|
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||SP
|FOXP1
|
|
|
|
|
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|
|-
|     Enteropathy-Associated T-cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|
|-
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease|| ||SP
|MYC
|
|
|
|
|
|
|-
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
|
|
|
|
|
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| ||SP
|
|
|
|
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP
|JAK2
|
|
|
|
|
|
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|Mycosis Fungoides||Disease|| ||SP
|
|
|
|
|
|
|-
|-
|Sézary Syndrome||Disease|| ||SP
|WT1
|DONE
|
|
|
|
|DONE
|
|
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|
|-
|-
|    Lymphomatoid  Papulosis||Disease|| ||SP
|CBL
|
|
|
|
|
|
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|
|-
|-
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||SP
|NF1
|
|
|
|
|
|
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|
|-
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||SP
|SUZ12
|
|
|
|
|
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
|
|
|
|
|
|
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|
|-
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease|| ||SP
|ERG
|
|
|
|
|
|-
|    Follicular T-cell  Lymphoma||Disease|| ||SP
|
|
|
|
|
|
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||SP
|
|
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Mahsa Khanlari
|EST2
|SP
|
|
|
|
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Mahsa Khanlari
|SP
|
|
|
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|
|-
|-
| || || ||
|RPS14
|
|
|
|
|
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
|
|
|
|
|
|
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|
|-
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
|RB1
|
|
|
|
|
|
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|
|-
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
|MPL
|
|
|
|
|
|
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|
|
|
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|
|
|
|
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease|| ||
|CHGA
|
|
|
|
|
|
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|
|
|
|
|
|
|-
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|CDH1
|
|
|
|
|
|
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|          Monomorphic  B-cell PTLD||Disease|| ||
|
|
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
|SRSF2
|
|
|
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
|
|
|
|
|
|
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
|
|
|
|
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
|DNMT1
|
|
|
|
|
|-
|Histiocytic Sarcoma||Disease|| ||
|
|
|
|
|
|
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
|
|
|
|
|
|
|-
|-
|   Langerhans Cell  Histiocytosis||Disease|| ||
|PRDX2
|
|
|
|
|
|-
|   Langerhans Cell  Sarcoma||Disease|| ||
|
|
|
|
|
|
|-
|Indeterminate Dendritic Cell Tumour||Disease|| ||
|
|
|
|
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
|ASXL1
|DONE
|
|
|
|
|DONE
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease|| ||
|
|
|
|
|
|
|-
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
|MN1
|
|
|
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease|| ||
|
|
|
|
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
|
|
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease|| ||
|SF3A1
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|EP300
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|JARID2
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|BRCA1
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|BRCA2
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|-
| || || ||
|
|
|
|
|
|
|}
|}
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"